Acute Corinary Syndrome
Help!
|
|
|
||||||
|---|---|---|---|---|---|---|---|---|
| eptifibatide (intergrilin) | Glycoprotein IIb/IIIc receptor antagonists (antiplatelet agent) | renal cleared
IV during PCI and 12-24 hours afterward
🗑
|
||||||
| tirofiban (aggrestat) | Glycoprotein IIb/IIIc receptor antagonists (antiplatelet agent) | renal cleared
IV during PCI and 12-24 hours afterward. AE bleeding thrombocytopenia monitor hematocrit and platelet counts
🗑
|
||||||
| UFH | antithrombin agent | for 48 hours
🗑
|
||||||
| Enoxaparin | antithrombin agent | not renal failure or dialysis BID daily preferred (or fond) in low risk and being treated with conservative medical strategy
🗑
|
||||||
| bivalirudin | antithrombin agent direct thrombin inhbitor | preferred agent if HIT present or suspected. doesn't require the use of Gpp IIb/IIIa receptor during PCI if this is used. not used in conservative treatment. reduced risk of bleeding compared to LMWH and UFH. can be continued for duration of stay
🗑
|
||||||
| fondaparinux | antithrombin agent | not in CrCL <30 mL/min. not recommended at time of PCI because will need another agent. preferred with enox, in low risk and being treated with conservative medical strategy
🗑
|
||||||
| oxygen | lower than 80
🗑
|
|||||||
| aspirin 325 |
🗑
|
|||||||
| morphine | those with refractory angina as analgesic and venodilator that lowers preload
🗑
|
|||||||
| IV metoprolol avoid IV when at risk for shock | beta blocker | decrease rate and oxygen demand, get it if don't show evidence of acutely low out put, no peripheral edema, JVD, rales of S3 heart sounds. give oral if SPB not >160
🗑
|
||||||
| streptokinase (streptase) | thrombolytic | potential antigenicity, Ci with prior exposure greater than 5 days
🗑
|
||||||
| anistrepalse (aminase) | thrombolytic | potential antigenicity, CI with prior exposure greater than 5 days
🗑
|
||||||
| alteplase (activase) | thrombolytic |
🗑
|
||||||
| reteplase (retavse) | thrombolytic | genetically modified plasminogen activator similar to t-PA with longer half life
🗑
|
||||||
| tenecteplase (TNK) | thrombolytic | high fibrin specificity longer half life and higher resistance to inhinbition by plasminogen activator inhibitor
🗑
|
||||||
| urokinase | non popular thrombolytic |
🗑
|
||||||
| abciximab (reoPro) | Glycoprotein IIb/IIIc receptor antagonists (antiplatelet agent) |
🗑
|
Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Created by:
lainylaina
Popular Pharmacology sets